E
DXCM icon

Ergoteles’s DexCom DXCM Stock Holding History

Ergoteles’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,339
Closed -$1.07M – 280
2023
Q2 		$1.07M Buy
8,339
+2,181
+35% +$264K 0.05% 447
2023
Q1 		$715K Sell
6,158
-120,423
-95% -$13.5M 0.03% 615
2022
Q4 		$14.3M Buy
126,581
+67,410
+114% +$7.4M 0.53% 34
2022
Q3 		$4.77M Sell
59,171
-115,406
-66% -$9.77M 0.17% 122
2022
Q2 		$13M Buy
174,577
+167,853
+2,496% +$15.3M 0.39% 62
2022
Q1 		$860K Buy
6,724
+2,536
+61% +$277K 0.03% 481
2021
Q4 		$562K Buy
+4,188
New +$602K 0.02% 598
2021
Q1 		– Sell
-2,400
Closed -$222K – 859
2020
Q4 		$222K Buy
+2,400
New +$214K 0.01% 585

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ergoteles's DXCM Position: Q3 2023 in Review

Ergoteles sold out of DexCom (DXCM) in Q3 2023, closing a stake of 8,339 shares — an estimated $1.07M sold.

Ergoteles first reported a position in DXCM in Q4 2020 and held it in 8 quarters. The position peaked at $14.3M in Q4 2022. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Ergoteles reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 8,339 DexCom shares in Q3 2023, an estimated $1.07M.
  • Ergoteles first reported a position in DexCom in Q4 2020 and held it in 8 quarters.
  • Ergoteles's DexCom position peaked at $14.3M in Q4 2022.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.